Good Clinical Practice

Despite not being a drug trial, nor a device trial, SafeBoosC III will be conducted in compliance with the guidelines of the Declaration of Helsinki, and of the International Conference on Harmonisation Good Clinical Practice.

Below you will find the Good Clinical Practice monitoring plan, and report templates for both initiation- and monitoring visits. All principal investigators must organize Good Clinical Practice monitoring in their own department.